Latest Breaking News On - Clinical study - Page 2 : vimarsana.com

FDA Grants Orphan Drug Designation to Tigilanol Tiglate in Soft Tissue Sarcoma

The FDA has granted an orphan drug designation to tigilanol tiglate for the treatment of patients with soft tissue sarcoma.

FDA Grants Orphan Drug Designation to Tigilanol Tiglate for Soft Tissue Sarcoma

Tigilanol tiglate is a novel, small molecule drug for the intratumoral treatment of solid tumors, inducing tumor cell death and stimulating immune response.

Ensysce Biosciences Announces Publication of Clinical Bioequivalence Manuscript

Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder

Allergan Aesthetics Showcases Commitment to Individuality, Innovation, and Integrity at IMCAS World Congress 2024

-- Expert-led symposium will explore key emerging themes in aesthetics, supported by injection session live from Allergan Aesthetics Center of Excellence in Italy -- -- New clinical data will be...

Microbot Medical (MBOT) Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission

Form 8-K Microbot Medical Inc. For: Jan 18

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical studyBRAINTREE, Mass., Jan. 18, 2024 --...

PanGIA Biotech Plans Expanded Multi-Cancer Early Detection Liquid Biopsy Study

Predictmedix AI Inc.: Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection